Melanoma: how much neoadjuvant treatment do we need to give?

Intervista a Michael A. Postow By 9 Dicembre 2024Dicembre 1st, 2025No Comments
Dai congressi

How much neoadjuvant treatment you give prior to surgery in patients with high risk receptable stage 3 melanoma? What do we know about that topic? We asked Michael A. Postow (Chief, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York) at Melanoma Bridge 2024.